Victor Kouassi – Page 5 – REVIVE

About Victor Kouassi

This author has not yet filled in any details.
So far Victor Kouassi has created 155 blog entries.

<br>Tackling the drug-resistance pandemic – 2020 and beyond</br><em> – by Laura J.V. Piddock</em> — 23 November 2020
Tackling the drug-resistance pandemic – 2020 and beyond – by Laura J.V. Piddock
more

<br>Why are new antibacterials failing as commercial products?</br><em> – by Patricia A. Bradford</em> — 19 November 2020
Why are new antibacterials failing as commercial products? – by Patricia A. Bradford
more

<br>COVID-19: Coinfection, secondary bacterial infections and AMR in India</br><em> – by Venkatasubramanian Ramasubramanian</em> — 12 November 2020
COVID-19: Coinfection, secondary bacterial infections and AMR in India – by Venkatasubramanian Ramasubramanian
more

Antibiotics and antimicrobial resistance — 16 October 2020
Antibiotics and antimicrobial resistance
more

<br>A lesson learned from COVID-19: The importance of non-inferiority (NI) trials for developing new antimicrobial agents before widespread need</br><em> – by John Rex</em> — 6 October 2020
A lesson learned from COVID-19: The importance of non-inferiority (NI) trials for developing new antimicrobial agents before widespread need ...
more

Discovery of new antibacterials using artificial intelligence (computational chemoinformatics) — 26 September 2020
Discovery of new antibacterials using artificial intelligence (computational chemoinformatics)
more

<br>Moving from paper to action – The status of National AMR Action Plans in African countries</br><em> – by Mirfin Mpundu</em> — 25 September 2020
Moving from paper to action – The status of National AMR Action Plans in African countries – by Mirfin Mpundu
more

Building better breakpoints: data and methods needed to determine breakpoints for new agents — 24 September 2020
Building better breakpoints: data and methods needed to determine breakpoints for new agents
more

Building Medtech Companies: Learn how to attract investment to fund product development and scale your company — 3 September 2020
Building Medtech Companies: Learn how to attract investment to fund product development and scale your company
more

How do we simultaneously manage the acute COVID-19 pandemic and escalating antibiotic resistance?

more